Merck parasiticide granted FDA emergency use nod for screwworm infestations in dogs

Merck (MRK) wins FDA emergency use authorization for its Bravecto for antiparasitic treatment Bravecto to treat new screwworm infestations in dogs. Read more here.

CryptoAlerta — análise de criptomoedas e mercado em tempo real